Skip to main content
. 2014 Apr 8;9(4):e94399. doi: 10.1371/journal.pone.0094399

Figure 4. Correlation between MAML2 rearrangement and expression of FLT1, HES1 and NR4A2 in pulmonary mucoepidermoid carcinomas.

Figure 4

A–B, Immunostaining for FLT1 in MAML2 rearranged tumor (A) and MAML2 non-rearranged tumor (B) (400×). C–E, Scattered plots showing correlation between MAML2 rearrangement and variation of the H-score for FLT1(C), HES1 (D) and NR4A2 (E).